Acadian Asset Management
LOGC

Acadian Asset Management’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Acadian Asset Management’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$13K Hold
2022
Q2 		$18K Hold
2022
Q1 		$32K Buy
2020
Q1 		– Sell
2019
Q4 		$15K Buy